595 related articles for article (PubMed ID: 24517996)
1. The effect of intravenous peramivir, compared with oral oseltamivir, on the outcome of post-influenza pneumococcal pneumonia in mice.
Tanaka A; Nakamura S; Seki M; Iwanaga N; Kajihara T; Kitano M; Homma T; Kurihara S; Imamura Y; Miyazaki T; Izumikawa K; Kakeya H; Yanagihara K; Kohno S
Antivir Ther; 2015; 20(1):11-9. PubMed ID: 24517996
[TBL] [Abstract][Full Text] [Related]
2. Intravenous peramivir inhibits viral replication, and leads to bacterial clearance and prevention of mortality during murine bacterial co-infection caused by influenza A(H1N1)pdm09 virus and Streptococcus pneumoniae.
Onishi M; Kitano M; Taniguchi K; Homma T; Kobayashi M; Yoshinaga T; Naito A; Sato A
Antiviral Res; 2015 May; 117():52-9. PubMed ID: 25752738
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of repeated intravenous injection of peramivir against influenza A (H1N1) 2009 virus infection in immunosuppressed mice.
Kitano M; Kodama M; Itoh Y; Kanazu T; Kobayashi M; Yoshida R; Sato A
Antimicrob Agents Chemother; 2013 May; 57(5):2286-94. PubMed ID: 23478960
[TBL] [Abstract][Full Text] [Related]
4. A single intramuscular injection of neuraminidase inhibitor peramivir demonstrates antiviral activity against novel pandemic A/California/04/2009 (H1N1) influenza virus infection in mice.
Bantia S; Kellogg D; Parker C; Upshaw R; Ilyushina NA; Babu YS
Antiviral Res; 2011 Apr; 90(1):17-21. PubMed ID: 21316393
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary immunostimulation with MALP-2 in influenza virus-infected mice increases survival after pneumococcal superinfection.
Reppe K; Radünzel P; Dietert K; Tschernig T; Wolff T; Hammerschmidt S; Gruber AD; Suttorp N; Witzenrath M
Infect Immun; 2015 Dec; 83(12):4617-29. PubMed ID: 26371127
[TBL] [Abstract][Full Text] [Related]
6. A clinical trial of intravenous peramivir compared with oral oseltamivir for the treatment of seasonal influenza in hospitalized adults.
Ison MG; Hui DS; Clezy K; O'Neil BJ; Flynt A; Collis PJ; Simon TJ; Alexander WJ
Antivir Ther; 2013; 18(5):651-61. PubMed ID: 23111657
[TBL] [Abstract][Full Text] [Related]
7. Combinations of oseltamivir and peramivir for the treatment of influenza A (H1N1) virus infections in cell culture and in mice.
Smee DF; Hurst BL; Wong MH; Tarbet EB; Babu YS; Klumpp K; Morrey JD
Antiviral Res; 2010 Oct; 88(1):38-44. PubMed ID: 20633577
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Antiviral Properties of Peramivir against H7N9 Avian Influenza Virus in an Experimental Mouse Model.
Farooqui A; Huang L; Wu S; Cai Y; Su M; Lin P; Chen W; Fang X; Zhang L; Liu Y; Zeng T; Paquette SG; Khan A; Kelvin AA; Kelvin DJ
Antimicrob Agents Chemother; 2015 Dec; 59(12):7255-64. PubMed ID: 26369969
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of repeated intravenous administration of peramivir against highly pathogenic avian influenza A (H5N1) virus in cynomolgus macaques.
Kitano M; Itoh Y; Ishigaki H; Nakayama M; Ishida H; Pham VL; Arikata M; Shichinohe S; Tsuchiya H; Kitagawa N; Kobayashi M; Yoshida R; Sato A; Le QM; Kawaoka Y; Ogasawara K
Antimicrob Agents Chemother; 2014 Aug; 58(8):4795-803. PubMed ID: 24913156
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic activity of intramuscular peramivir in mice infected with a recombinant influenza A/WSN/33 (H1N1) virus containing the H275Y neuraminidase mutation.
Abed Y; Pizzorno A; Boivin G
Antimicrob Agents Chemother; 2012 Aug; 56(8):4375-80. PubMed ID: 22664977
[TBL] [Abstract][Full Text] [Related]
11. Combination effects of peramivir and favipiravir against oseltamivir-resistant 2009 pandemic influenza A(H1N1) infection in mice.
Park S; Kim JI; Lee I; Lee S; Hwang MW; Bae JY; Heo J; Kim D; Jang SI; Kim H; Cheong HJ; Song JW; Song KJ; Baek LJ; Park MS
PLoS One; 2014; 9(7):e101325. PubMed ID: 24992479
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the binding affinities of peramivir and oseltamivir carboxylate to the neuraminidase enzyme.
Bantia S; Upshaw R; Babu YS
Antiviral Res; 2011 Sep; 91(3):288-91. PubMed ID: 21722670
[TBL] [Abstract][Full Text] [Related]
13. The Flavonoid Isoliquiritigenin Reduces Lung Inflammation and Mouse Morbidity during Influenza Virus Infection.
Traboulsi H; Cloutier A; Boyapelly K; Bonin MA; Marsault É; Cantin AM; Richter MV
Antimicrob Agents Chemother; 2015 Oct; 59(10):6317-27. PubMed ID: 26248373
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic efficacy of peramivir against H5N1 highly pathogenic avian influenza viruses harboring the neuraminidase H275Y mutation.
Kobayashi M; Kodama M; Noshi T; Yoshida R; Kanazu T; Nomura N; Soda K; Isoda N; Okamatsu M; Sakoda Y; Yamano Y; Sato A; Kida H
Antiviral Res; 2017 Mar; 139():41-48. PubMed ID: 28012921
[TBL] [Abstract][Full Text] [Related]
15. Anti-influenza virus activity of peramivir in mice with single intramuscular injection.
Bantia S; Arnold CS; Parker CD; Upshaw R; Chand P
Antiviral Res; 2006 Jan; 69(1):39-45. PubMed ID: 16325932
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of delayed treatment of China-made Peramivir with repeated intravenous injections in a mouse influenza model: from clinical experience to basal experiment.
Li Z; Li R; Li J; Xie H; Hao Y; Du Q; Chen T; Li Y; Chen R; Yang Z; Zhong N
BMC Infect Dis; 2016 Jul; 16():325. PubMed ID: 27392915
[TBL] [Abstract][Full Text] [Related]
17. Lethal coinfection of influenza virus and Streptococcus pneumoniae lowers antibody response to influenza virus in lung and reduces numbers of germinal center B cells, T follicular helper cells, and plasma cells in mediastinal lymph Node.
Wu Y; Tu W; Lam KT; Chow KH; Ho PL; Guan Y; Peiris JS; Lau YL
J Virol; 2015 Feb; 89(4):2013-23. PubMed ID: 25428873
[TBL] [Abstract][Full Text] [Related]
18. Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza.
McCullers JA
J Infect Dis; 2004 Aug; 190(3):519-26. PubMed ID: 15243927
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of peramivir and oseltamivir on the rise in platelet count in patients with or without proven influenza
.
Kim YG; Ko SY; Lee SW
Int J Clin Pharmacol Ther; 2019 Mar; 57(3):152-159. PubMed ID: 30526812
[TBL] [Abstract][Full Text] [Related]
20. In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RJW-270201.
Sidwell RW; Smee DF; Huffman JH; Barnard DL; Bailey KW; Morrey JD; Babu YS
Antimicrob Agents Chemother; 2001 Mar; 45(3):749-57. PubMed ID: 11181355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
